Retatrutide
SKU: SKU-ART-010
Select Dosage:
$85.00 AUD
Compound Specifications
Research Notes
Retatrutide is a synthetic triple agonist peptide that simultaneously engages the GLP-1, GIP, and glucagon receptors. Multi-receptor agonism is an active area of metabolic research, building on the established biology of incretin signalling and expanding the investigation of coordinated receptor engagement.
The compound is being studied in an extensive clinical development programme, including the TRIUMPH series of trials. These studies examine metabolic endpoints across diverse research populations and have contributed substantially to the understanding of multi-agonist pharmacology in preclinical and clinical research settings.
For Australian laboratories, retatrutide represents a well-characterised reference compound for incretin pathway research, with an established profile in the published literature.
Supply & Quality
All products are research compounds intended for laboratory research use only. Not for human or veterinary use. Kinetic Labs does not provide dosing guidance, therapeutic recommendations, or medical advice of any kind.